These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 21107293)
21. S-1 plus cisplatin combination chemotherapy in patients with advanced non-small cell lung cancer: a multi-institutional phase II trial. Ichinose Y; Yoshimori K; Sakai H; Nakai Y; Sugiura T; Kawahara M; Niitani H Clin Cancer Res; 2004 Dec; 10(23):7860-4. PubMed ID: 15585618 [TBL] [Abstract][Full Text] [Related]
22. Gemcitabine and vinorelbine followed by weekly docetaxel in patients with advanced non-small-cell lung cancer: a phase II trial of sequential chemotherapy. Cobo Dols M; Villar Chamorro E; Alés Díaz I; Gil Calle S; Alcalde García J; Gutiérrez Calderón V; Carabantes Ocón F; Montesa Pino A; Bretón García JJ; Benavides Orgaz M Clin Transl Oncol; 2006 Oct; 8(10):742-9. PubMed ID: 17074673 [TBL] [Abstract][Full Text] [Related]
23. Gemcitabine and cisplatin versus vinorelbine and cisplatin versus ifosfamide+gemcitabine followed by vinorelbine and cisplatin versus vinorelbine and cisplatin followed by ifosfamide and gemcitabine in stage IIIB-IV non small cell lung carcinoma: a prospective randomized phase III trial of the Gruppo Oncologico Italia Meridionale. Gebbia V; Galetta D; Caruso M; Verderame F; Pezzella G; Valdesi M; Borsellino N; Pandolfo G; Durini E; Rinaldi M; Loizzi M; Gebbia N; Valenza R; Tirrito ML; Varvara F; Colucci G; Lung Cancer; 2003 Feb; 39(2):179-89. PubMed ID: 12581571 [TBL] [Abstract][Full Text] [Related]
24. Gemcitabine, vinorelbine, and Cisplatin in the treatment of advanced nonsmall cell lung cancer. Hasturk S; Hatabay N; Ece F; Karatasli M; Hanta I Am J Clin Oncol; 2009 Jun; 32(3):280-5. PubMed ID: 19433960 [TBL] [Abstract][Full Text] [Related]
25. Phase I and pharmacokinetic study of IV vinflunine in combination with gemcitabine for treatment of advanced non-small cell lung cancer in Chemonaive patients. Tournoux-Facon C; Senellart H; Lemarie E; Tourani JM; Favrel S; Pouget JC; Pinel MC; Bennouna J J Thorac Oncol; 2011 Jul; 6(7):1247-53. PubMed ID: 21610520 [TBL] [Abstract][Full Text] [Related]
26. First-line gemcitabine with cisplatin or epirubicin in advanced non-small-cell lung cancer: a phase III trial. Wachters FM; Van Putten JW; Kramer H; Erjavec Z; Eppinga P; Strijbos JH; de Leede GP; Boezen HM; de Vries EG; Groen HJ Br J Cancer; 2003 Oct; 89(7):1192-9. PubMed ID: 14520444 [TBL] [Abstract][Full Text] [Related]
27. Administration of pemetrexed immediately following gemcitabine as front-line therapy in advanced non-small cell lung cancer: a phase II trial. Treat J; Bonomi P; McCleod M; Christiansen NP; Mintzer DM; Monberg MJ; Ye Z; Chen R; Obasaju CK Lung Cancer; 2006 Jul; 53(1):77-83. PubMed ID: 16730854 [TBL] [Abstract][Full Text] [Related]
28. Efficacy and survival-associated factors with gefitinib combined with cisplatin and gemcitabine for advanced non- small cell lung cancer. Fang H; Lin RY; Sun MX; Wang Q; Zhao YL; Yu JL; Tian Y; Wang XY Asian Pac J Cancer Prev; 2014; 15(24):10967-70. PubMed ID: 25605210 [TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of cisplatin/pemetrexed versus cisplatin/gemcitabine as first-line treatment in East Asian patients with advanced non-small cell lung cancer: results of an exploratory subgroup analysis of a phase III trial. Yang CH; Simms L; Park K; Lee JS; Scagliotti G; Orlando M J Thorac Oncol; 2010 May; 5(5):688-95. PubMed ID: 20150825 [TBL] [Abstract][Full Text] [Related]
30. A randomized phase II trial of adjuvant chemotherapy with bi-weekly carboplatin plus paclitaxel versus carboplatin plus gemcitabine in patients with completely resected non-small cell lung cancer. Uramoto H; Nakanishi R; Nagashima A; Uchiyama A; Inoue M; Osaki T; Yoshimatsu T; Sakata H; Nakanishi K; Yasumoto K Anticancer Res; 2010 Nov; 30(11):4695-9. PubMed ID: 21115926 [TBL] [Abstract][Full Text] [Related]
31. Randomized phase II trial of sequential chemotherapy in advanced non-small cell lung cancer (SWOG 9806): carboplatin/gemcitabine followed by paclitaxel or cisplatin/vinorelbine followed by docetaxel. Edelman MJ; Clark JI; Chansky K; Albain K; Bhoopalam N; Weiss GR; Giguere JK; Kelly K; Crowley J; Gandara DR Clin Cancer Res; 2004 Aug; 10(15):5022-6. PubMed ID: 15297403 [TBL] [Abstract][Full Text] [Related]
32. Promising survival in patients with recurrent non-small cell lung cancer treated with docetaxel and gemcitabine in combination as second-line therapy. Huang CH; Millenson MM; Sherman EJ; Borghaei H; Mintzer DM; Cohen RB; Staddon AP; Seldomridge J; Treat OJ; Tuttle H; Ruth KJ; Langer CJ J Thorac Oncol; 2008 Sep; 3(9):1032-8. PubMed ID: 18758307 [TBL] [Abstract][Full Text] [Related]
33. Neoadjuvant chemotherapy with gemcitabine-containing regimens in patients with early-stage non-small cell lung cancer. Detterbeck FC; Socinski MA; Gralla RJ; Edelman MJ; Jahan TM; Loesch DM; Limentani SA; Govindan R; Zaman MB; Ye Z; Monberg MJ; Obasaju CK J Thorac Oncol; 2008 Jan; 3(1):37-45. PubMed ID: 18166839 [TBL] [Abstract][Full Text] [Related]
34. Efficacy of pemetrexed as second-line therapy in advanced NSCLC after either treatment-free interval or maintenance therapy with gemcitabine or erlotinib in IFCT-GFPC 05-02 phase III study. Bylicki O; Ferlay C; Chouaid C; Lavolé A; Barlési F; Dubos C; Westeel V; Créquit J; Corre R; Vergnenègre A; Monnet I; Le Caer H; Fournel P; Vaylet F; Falchero L; Poudenx M; Linard P; Pérol D; Zalcman G; Pérol M J Thorac Oncol; 2013 Jul; 8(7):906-14. PubMed ID: 23591160 [TBL] [Abstract][Full Text] [Related]
35. [Gemcitabine plus cisplatin versus gemcitabine plus vinorelbine in treatment of advanced non-small cell lung cancer (NSCLC)]. Zhang L; Zhang Y; Li N; Xu F; Pan ZK; Guan ZZ Ai Zheng; 2004 Nov; 23(11 Suppl):1455-8. PubMed ID: 15566656 [TBL] [Abstract][Full Text] [Related]
36. Prospective phase II trial of a combination of gemcitabine and UFT as first-line treatment in elderly patients with advanced non-small cell lung cancer. Baek JH; Kim H; Ahn JJ; Jegal Y; Seo KW; Ra SW; Park CR; Jung JP; Kim JW; Lee YJ; Cha HJ; Kwon WJ; Noh YJ; Oh S; Park JH; Min YJ Lung Cancer; 2012 Jun; 76(3):368-72. PubMed ID: 22192919 [TBL] [Abstract][Full Text] [Related]
37. Phase III trial of gemcitabine and carboplatin versus mitomycin, ifosfamide, and cisplatin or mitomycin, vinblastine, and cisplatin in patients with advanced nonsmall cell lung carcinoma. Danson S; Middleton MR; O'Byrne KJ; Clemons M; Ranson M; Hassan J; Anderson H; Burt PA; Fairve-Finn C; Stout R; Dowd I; Ashcroft L; Beresford C; Thatcher N Cancer; 2003 Aug; 98(3):542-53. PubMed ID: 12879472 [TBL] [Abstract][Full Text] [Related]
38. High response of second-line chemotherapy with pemetrexed or gemcitabine combined with carboplatin in patients with non-small-cell lung cancer experiencing progression following 6 months after concluding platinum-based chemotherapy. Arrieta O; Villarreal-Garza C; Pachuca D; Michel Ortega RM; Martinez-Barrera L; Flores-Estrada D; Astorga A Med Oncol; 2011 Mar; 28(1):300-6. PubMed ID: 20049560 [TBL] [Abstract][Full Text] [Related]
39. A phase II study of days 1 and 8 combination of docetaxel plus gemcitabine for the second-line treatment of patients with advanced non-small-cell lung cancer and good performance status. Cobo M; Gutiérrez V; Alcaide J; Alés I; Villar E; Gil S; Durán G; Martínez J; Carabantes F; Bretón JJ; Benavides M Lung Cancer; 2007 May; 56(2):255-62. PubMed ID: 17276537 [TBL] [Abstract][Full Text] [Related]
40. Prognostic and predictive factors in a randomized phase III trial comparing cisplatin-pemetrexed versus cisplatin-gemcitabine in advanced non-small-cell lung cancer. Syrigos KN; Vansteenkiste J; Parikh P; von Pawel J; Manegold C; Martins RG; Simms L; Sugarman KP; Visseren-Grul C; Scagliotti GV Ann Oncol; 2010 Mar; 21(3):556-561. PubMed ID: 19828561 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]